1.6600
-0.0900
(-5.14%)
As of 9:59:01 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-10,637
-10,637
-21,657
-39,755
-37,703
Investing Cash Flow
--
--
-3
-10
-7
Financing Cash Flow
7,485
7,485
6,201
32,214
63,456
End Cash Position
1,443
1,443
4,595
20,054
27,605
Interest Paid Supplemental Data
374
374
885
--
--
Capital Expenditure
-11
--
-3
-10
-7
Issuance of Capital Stock
5,911
5,911
9,293
22,702
36,983
Issuance of Debt
7,079
7,079
943
10,020
--
Repayment of Debt
-8,575
-8,575
-4,035
-518
-1,276
Free Cash Flow
-10,637
-10,637
-21,660
-39,765
-37,710
12/31/2021 - 5/27/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0T20.F Traws Pharma, Inc.
0.0000
-100.00%
2X10.DU Abivax SA
5.15
+0.98%
BTTAY Biotest Aktiengesellschaft
24.23
0.00%
5LH0.F Guard Therapeutics International AB (publ)
1.0200
-2.86%
3EE0.F Kancera AB (publ)
0.0920
-7.91%
6JU0.F BioCardia, Inc.
0.0000
-100.00%
6DW.F D. Western Therapeutics Institute, Inc.
0.5550
-5.93%
5IU.F Isofol Medical AB (publ)
0.1500
+1.56%
2DE0.F Genprex, Inc.
0.0000
-100.00%
2I9.F Karolinska Development AB (publ)
0.0626
-14.25%